A basis for the pathological oscillations in basal ganglia: The crucial role of dopamine

NeuroReport

Volumn 22, Issue 4, 2011, Pages 151-156

  Weinberger, Moran ^a   Dostrovsky, Jonathan O ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

activity; basal ganglia; dopamine; oscillations; Parkinson's disease; subthalamic nucleus

Indexed keywords

DOPAMINE;

ADRENERGIC TRANSMISSION; BASAL GANGLION; BRAIN NERVE CELL; GLOBUS PALLIDUS; HISTOPATHOLOGY; NERVE CELL EXCITABILITY; NONHUMAN; OSCILLATION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STRIATE CORTEX; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; BIOLOGICAL CLOCKS; CORTICAL SYNCHRONIZATION; DOPAMINE; HUMANS; PARKINSON DISEASE;

EID: 79951875033     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328342ba50     Document Type: Review

References (40)

1. Wichmann T, DeLong MR. Deep brain stimulation for neurologic and neuropsychiatric disorders. Neuron 2006; 52:197-204. (Pubitemid 44466362)
2. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 2003; 18:357-363. (Pubitemid 36527275)
3. Sharott A, Magill PJ, Harnack D, Kupsch A, Meissner W, Brown P. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur J Neurosci 2005; 21:1413-1422. (Pubitemid 40516640)
4. Magill PJ, Bolam JP, Bevan MD. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 2001; 106:313-330. (Pubitemid 32889632)
5. Williams D, Tijssen M, Van Bruggen G, Bosch A, Insola A, Di Lazzaro V, et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002; 125:1558-1569. (Pubitemid 34755170)
6. Rivlin-Etzion M, Marmor O, Saban G, Rosin B, Haber SN, Vaadia E, et al. Low-pass filter properties of basal ganglia cortical muscle loops in the normal and MPTP primate model of parkinsonism. J Neurosci 2008; 28:633-649. (Pubitemid 351159030)
7. Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007; 30:357-364. (Pubitemid 46994777)
8. Tseng KY, Kasanetz F, Kargieman L, Riquelme LA, Murer MG. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 2001; 21:6430-6439. (Pubitemid 32737775)
9. Murer MG, Tseng KY, Kasanetz F, Belluscio M, Riquelme LA. Brain oscillations, medium spiny neurons, and dopamine. Cell Mol Neurobiol 2002; 22:611-632. (Pubitemid 36169211)
10. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, et al. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004; 42:653-663. (Pubitemid 38639883)
11. Onn SP, Grace AA. Alterations in electrophysiological activity and dye coupling of striatal spiny and aspiny neurons in dopamine-denervated rat striatum recorded in vivo. Synapse 1999; 33:1-15. (Pubitemid 29269945)
12. Walters JR, Hu D, Itoga CA, Parr-Brownlie LC, Bergstrom DA. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. Neuroscience 2007; 144:762-776. (Pubitemid 44856757)
13. Floran B, Floran L, Sierra A, Aceves J. D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 1997; 237:1-4. (Pubitemid 27521151)
14. Cooper AJ, Stanford IM. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology 2001; 41:62-71. (Pubitemid 32607645)
15. Shin RM, Masuda M, Miura M, Sano H, Shirasawa T, Song WJ, et al. Dopamine D4 receptor-induced postsynaptic inhibition of GABAergic currents in mouse globus pallidus neurons. J Neurosci 2003; 23:11662-11672. (Pubitemid 38021293)
16. Ferre S, O'Connor WT, Svenningsson P, Bjorklund L, Lindberg J, Tinner B, et al. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 1996; 8:1545-1553.
17. Kliem MA, Maidment NT, Ackerson LC, Chen S, Smith Y, Wichmann T. Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys. J Neurophysiol 2007; 98:1489-1500. (Pubitemid 47435897)
18. Kliem MA, Pare JF, Khan ZU, Wichmann T, Smith Y. Ultrastructural localization and function of dopamine D1-like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. Eur J Neurosci 2010; 31:836-851.
19. Baufreton J, Zhu ZT, Garret M, Bioulac B, Johnson SW, Taupignon AI. Dopamine receptors set the pattern of activity generated in subthalamic neurons. FASEB J 2005; 19:1771-1777. (Pubitemid 41598760)
20. Bevan MD, Magill PJ, Hallworth NE, Bolam JP, Wilson CJ. Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABA-A IPSPs. J Neurophysiol 2001; 87:1348-1362. (Pubitemid 34670802)
21. Beurrier C, Congar P, Bioulac B, Hammond C. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci 1999; 19:599-609. (Pubitemid 29036011)
22. Bevan MD, Wilson CJ, Bolam JP, Magill PJ. Equilibrium potential of GABA(A) current and implications for rebound burst firing in rat subthalamic neurons in vitro. J Neurophysiol 2000; 83:3169-3172. (Pubitemid 30321506)
23. Baufreton J, Garret M, Rivera A, De la Calle A, Gonon F, Dufy B, et al. D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci 2003; 23:816-825. (Pubitemid 36206172)
24. Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels. J Neurophysiol 2008; 99:442-459. (Pubitemid 351253208)
25. Shen KZ, Johnson SW. Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 2000; 525:331-341. (Pubitemid 30398364)
26. Baufreton J, Bevan MD. D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus. J Physiol 2008; 586:2121-2142. (Pubitemid 351524567)
27. Hassani OK, Feger J. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine- lesioned rats: an electrophysiological and c-Fos study. Neuroscience 1999; 92:533-543. (Pubitemid 29268041)
28. Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999; 400:677-682.
29. Zhu Z, Bartol M, Shen K, Johnson SW. Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa. Brain Res 2002; 945:31-40. (Pubitemid 34756574)
30. Hernandez A, Ibanez-Sandoval O, Sierra A, Valdiosera R, Tapia D, Anaya V, et al. Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine receptors. J Neurophysiol 2006; 96:2877-2888. (Pubitemid 44837837)
31. Goldberg JA, Kats SS, Jaeger D. Globus pallidus discharge is coincident with striatal activity during global slow wave activity in the rat. J Neurosci 2003; 23:10058-10063. (Pubitemid 37392552)
32. Baufreton J, Atherton JF, Surmeier DJ, Bevan MD. Enhancement of excitatory synaptic integration by GABAergic inhibition in the subthalamic nucleus. J Neurosci 2005; 25:8505-8517. (Pubitemid 41324736)
33. Bevan MD, Hallworth NE, Baufreton J. GABAergic control of the subthalamic nucleus. Prog Brain Res 2007; 160:173-188. (Pubitemid 46702291)
34. Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002; 22:4639-4653.
35. Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, et al. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol 2006; 96:3248-3256. (Pubitemid 44837869)
36. Ray NJ, Jenkinson N, Wang S, Holland P, Brittain JS, Joint C, et al. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol 2008; 213:108-113.
37. Kuhn AA, Tsui A, Aziz T, Ray N, Brucke C, Kupsch A, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol 2009; 215:380-387.
38. Weinberger M, Hutchison WD, Lozano AM, Hodaie M, Dostrovsky JO. Increased gamma oscillatory activity in the subthalamic nucleus during tremor in Parkinson's disease patients. J Neurophysiol 2009; 101:789-802.
39. Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996; 16:2671-2683. (Pubitemid 26122683)
40. Gaynor LM, Kuhn AA, Dileone M, Litvak V, Eusebio A, Pogosyan A, et al. Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. Eur J Neurosci 2008; 28:1686-1695.